BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21167567)

  • 1. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction.
    Semaan A; Munkarah AR; Arabi H; Bandyopadhyay S; Seward S; Kumar S; Qazi A; Hussein Y; Morris RT; Ali-Fehmi R
    Gynecol Oncol; 2011 Apr; 121(1):181-6. PubMed ID: 21167567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival.
    Ali-Fehmi R; Morris RT; Bandyopadhyay S; Che M; Schimp V; Malone JM; Munkarah AR
    Am J Obstet Gynecol; 2005 Mar; 192(3):819-25. PubMed ID: 15746677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation and maturation of intratumoral blood vessels in women with malignant ovarian tumors assessed with cancer stem cells marker nestin and platelet derived growth factor PDGF-B.
    Czekierdowska S; Stachowicz N; Chróściel M; Czekierdowski A
    Ginekol Pol; 2017; 88(3):120-128. PubMed ID: 28397199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance.
    Krishna Priya S; Kumar K; Hiran KR; Bindhu MR; Nagare RP; Vijaykumar DK; Ganesan TS
    Int J Clin Oncol; 2017 Feb; 22(1):107-117. PubMed ID: 27567920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.
    Kurokawa T; Yoshida Y; Kawahara K; Tsuchida T; Okazawa H; Fujibayashi Y; Yonekura Y; Kotsuji F
    Int J Cancer; 2004 May; 109(6):926-32. PubMed ID: 15027127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
    Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
    Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin I correlates with VEGFR-2 and cell proliferation in human epithelial ovarian cancer.
    Cybulski M; Jarosz B; Nowakowski A; Jeleniewicz W; Seroczyński P; Mazurek-Kociubowska M
    Gynecol Oncol; 2012 Oct; 127(1):217-22. PubMed ID: 22772062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.
    Szubert S; Moszynski R; Michalak S; Nowicki M; Sajdak S; Szpurek D
    Microvasc Res; 2016 Sep; 107():91-6. PubMed ID: 27312585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis.
    Tsukioka M; Matsumoto Y; Noriyuki M; Yoshida C; Nobeyama H; Yoshida H; Yasui T; Sumi T; Honda K; Ishiko O
    Oncol Rep; 2007 Aug; 18(2):361-7. PubMed ID: 17611657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of thymidine phosphorylase and vascular endothelial growth factor in epithelial ovarian cancer: correlation with angiogenesis and progression of the tumor.
    Hata K; Fujiwaki R; Nakayama K; Maede Y; Fukumoto M; Miyazaki K
    Anticancer Res; 2000; 20(5C):3941-9. PubMed ID: 11268481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
    APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian serous carcinoma: relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression.
    Crasta JA; Mishra S; Vallikad E
    Int J Gynecol Pathol; 2011 Nov; 30(6):521-6. PubMed ID: 21979585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of tumor angiogenesis in epithelial ovarian cancer.
    Obermair A; Wasicky R; Kaider A; Preyer O; Lösch A; Leodolter S; Kölbl H
    Cancer Lett; 1999 Apr; 138(1-2):175-82. PubMed ID: 10378790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of microvessel density and vascular endothelial growth factor expression in advanced ovarian serous carcinoma.
    Raspollini MR; Amunni G; Villanucci A; Baroni G; Boddi V; Taddei GL
    Int J Gynecol Cancer; 2004; 14(5):815-23. PubMed ID: 15361189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of microvessel density on ovarian carcinogenesis.
    Stone PJ; Goodheart MJ; Rose SL; Smith BJ; DeYoung BR; Buller RE
    Gynecol Oncol; 2003 Sep; 90(3):566-71. PubMed ID: 13678725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels of PTEN, HIF-1α, and VEGF as prognostic factors in ovarian cancer.
    Shen W; Li HL; Liu L; Cheng JX
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(11):2596-2603. PubMed ID: 28678326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer.
    El Behery MM; Seksaka MA; Ibrahiem MA; Saleh HS; El Alfy Y
    Arch Gynecol Obstet; 2013 Dec; 288(6):1371-6. PubMed ID: 23708323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF18 as a potential biomarker in serous and mucinous ovarian tumors.
    El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA
    Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1α and vascular endothelial growth factor.
    Zhang Y; Xu Y; Ma J; Pang X; Dong M
    Sci Rep; 2017 Jan; 7():40524. PubMed ID: 28091613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
    Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.